BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
PRINCIPAL INVESTORS: Medtronic Inc.
Essex Woodlands
Vector Later-Stage Equity Fund
CIBC Wood Gundy
BUSINESS STRATEGY: Develop technology for processing other universally transplantable tissue
grafts and extended preservation of transfusable blood products
AGREEMENTS: Name Products Content of Agreement Date
LifeCore
AlloDerm for periodontal exclusive distribution 6/97
Biomedical Inc. procedures
agreement for the
U.S.
Medtronic Inc. porcine-tissue heart
valves
licensing agreement 3/94
US Army Institute AlloDerm grafts for use development 1/97
of Surgical in neurological,
agreement--LifeCell
Research
dermatological and to receive $1.07M
cardiovascular surgery over two years in
product
development
funding and will use
tissue preservation
technology to
develop vascular
grafts for bypass
surgery
US Navy ThromboSol platelet $600K development 8/98
storage solution funding
RESEARCH & DEVELOPMENT: Universal Tissue Grafts, including skin, vascular conduits and heart valves
Products for extending the shelf life of transfusable blood cells including red
blood cells and platelets
PRODUCTS ON MARKET: AlloDerm® - processed tissue products for grafting of third degree burns,
grafting and guided tissue regeneration in periodontal surgery and tissue
repair in plastic reconstructive surgery
Cymetra® - version of AlloDerm in particulate form for the correction of soft
tissue defects
Repliform® - acellular tissue matrix for urologic and gynecologic procedures
Graft Jacket® - accelular tissue matrix for orthopedic applications
AlloCraftDBM - for bone grafting procedures
LifeSensors Inc.
271 Great Valley Parkway, Suite 100
Malvern PA 19355, US
Phone: (610) 644-8845; Fax: (610) 644-8616
Web: www.lifesensors.com
E-mail: info@lifesensors.com
KEY PERSONNEL: Tauseef R. Butt, Ph.D.; President and CEO
Michael R. Mattern, Ph.D.; VP, Research
John Hall; VP, Business Development
Bob Griess; Director, Finance
EMPLOYEES: 12 employees
HISTORY: Founded in July 1996
Began biotech R&D December 1996
FACILITIES: 5,000 sq. ft. headquarters
STOCK-FINANCIAL HISTORY: Privately held
SUBSIDIARY OF: Gene Transcription Technology
Copyright ©2006 AHC Media ® 225